Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
0.8132
-0.0267 (-3.18%)
At close: Nov 6, 2026, 4:00 PM EST
0.8500
+0.0368 (4.53%)
After-hours: Nov 6, 2026, 7:30 PM EST
Organogenesis Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 349.58 | 563.03 | 482.04 | 433.14 | 450.89 | 467.36 |
Other Revenue | 2.46 | 1.14 | - | - | - | - |
| 352.05 | 564.17 | 482.04 | 433.14 | 450.89 | 467.36 | |
Revenue Growth | -24.33% | 17.04% | 11.29% | -3.94% | -3.52% | 38.15% |
Cost of Revenue | 116.08 | 132.34 | 115.74 | 106.48 | 105.02 | 114.2 |
Gross Profit | 235.97 | 431.83 | 366.3 | 326.66 | 345.87 | 353.16 |
Selling, General & Admin | 263.9 | 325.72 | 294.51 | 265.96 | 281.54 | 249.48 |
Research & Development | 51.71 | 44.54 | 50.27 | 44.38 | 39.76 | 30.74 |
Operating Expenses | 315.6 | 370.26 | 344.78 | 310.34 | 321.3 | 280.22 |
Operating Income | -79.63 | 61.57 | 21.52 | 16.32 | 24.57 | 72.94 |
Interest Expense | - | - | -1.54 | -2.19 | -2.01 | -7.24 |
Interest & Investment Income | 0.69 | 2.28 | - | - | - | - |
Other Non Operating Income (Expenses) | -0.16 | -0.01 | 0.02 | 0.06 | -0.01 | -0.01 |
EBT Excluding Unusual Items | -79.1 | 63.84 | 19.99 | 14.19 | 22.55 | 65.69 |
Merger & Restructuring Charges | -0.52 | -0.52 | - | -3.8 | -2.27 | -4.7 |
Gain (Loss) on Sale of Assets | -0.75 | -11.18 | - | - | - | - |
Asset Writedown | - | - | -22.8 | - | - | - |
Other Unusual Items | -5.18 | -5.18 | - | - | - | 2.1 |
Pretax Income | -85.55 | 46.97 | -2.81 | 10.39 | 20.28 | 63.09 |
Income Tax Expense | 49.81 | 9.94 | -3.67 | 5.45 | 4.75 | -31.12 |
Earnings From Continuing Operations | -135.35 | 37.03 | 0.86 | 4.95 | 15.53 | 94.2 |
Net Income | -135.35 | 37.03 | 0.86 | 4.95 | 15.53 | 94.2 |
Preferred Dividends & Other Adjustments | 17.79 | 17.01 | 1.8 | - | - | - |
Net Income to Common | -153.15 | 20.02 | -0.94 | 4.95 | 15.53 | 94.2 |
Net Income Growth | - | - | - | -68.16% | -83.51% | 446.61% |
Shares Outstanding (Basic) | 128 | 127 | 132 | 131 | 130 | 128 |
Shares Outstanding (Diluted) | 128 | 130 | 132 | 133 | 132 | 134 |
Shares Change | 0.53% | -1.08% | -0.81% | 0.27% | -0.96% | 20.03% |
EPS (Basic) | -1.20 | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 |
EPS (Diluted) | -1.20 | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 |
EPS Growth | - | - | - | -68.44% | -82.94% | 366.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.06 | -24.46 | 4.18 | 6.55 | -9.04 | 30.76 |
Free Cash Flow Per Share | - | -0.19 | 0.03 | 0.05 | -0.07 | 0.23 |
Gross Margin | 67.03% | 76.54% | 75.99% | 75.42% | 76.71% | 75.56% |
Operating Margin | -22.62% | 10.91% | 4.46% | 3.77% | 5.45% | 15.61% |
Profit Margin | -43.50% | 3.55% | -0.19% | 1.14% | 3.45% | 20.16% |
Free Cash Flow Margin | -0.02% | -4.34% | 0.87% | 1.51% | -2.00% | 6.58% |
EBITDA | -61.35 | 80.16 | 38.54 | 31.69 | 35.3 | 83.67 |
EBITDA Margin | -17.43% | 14.21% | 8.00% | 7.32% | 7.83% | 17.90% |
D&A For EBITDA | 18.28 | 18.6 | 17.03 | 15.37 | 10.73 | 10.73 |
EBIT | -79.63 | 61.57 | 21.52 | 16.32 | 24.57 | 72.94 |
EBIT Margin | -22.62% | 10.91% | 4.46% | 3.77% | 5.45% | 15.61% |
Effective Tax Rate | - | 21.16% | - | 52.41% | 23.42% | - |
Revenue as Reported | 352.05 | 564.17 | 482.04 | 433.14 | - | - |
Advertising Expenses | - | 5.84 | 3.83 | 5.23 | 4.81 | 5.52 |